Block 7: Musculoskeletal System                      Limbsalvage of                Bone and Soft-Tissue Tumors            ...
Block 7: Musculoskeletal System   Bone and Soft-Tissue Tumors  2
Block 7: Musculoskeletal System        Bone and Soft-Tissue Tumors                             Enchondroma                ...
Block 7: Musculoskeletal System                                  Bone and Soft-Tissue Tumors  4
Block 7: Musculoskeletal System         Clinical Approach to Musculoskeletal Tumors                                       ...
Block 7: Musculoskeletal System               Bone and Soft-Tissue Tumors          Surgical Margin of Musculoskeletal Tumo...
Block 7: Musculoskeletal System                                  Material and Method-1                  Time: 1989---2005 ...
Block 7: Musculoskeletal System                                  Material and Method-2   Anatomic location: distal femur– ...
Block 7: Musculoskeletal System                                  Results-1  9
Block 7: Musculoskeletal System                             Results-21. Functional scores of M-S Tumor Society: (motion , ...
Block 7: Musculoskeletal System                                  Discussion             1. Satisfied functional result    ...
Block 7: Musculoskeletal System      Malignant Tumor Non-Resection                    Resection IORT     Re-Implantation B...
Block 7: Musculoskeletal System                       Bone and Soft-Tissue TumorsBone Cancers                             ...
Block 7: Musculoskeletal SystemSoft-tissue Sarcomas                                                    KMU PRACTICE GUIDEL...
Block 7: Musculoskeletal System   Bone and Soft-Tissue Tumors         Summary / take home message            Oncologic te...
Block 7: Musculoskeletal System    Bone and Soft-Tissue Tumors                                  THANKS FOR YOUR ATTENTION 16
Upcoming SlideShare
Loading in …5
×

骨腫瘤之治療 簡松雄

816 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
816
On SlideShare
0
From Embeds
0
Number of Embeds
45
Actions
Shares
0
Downloads
11
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

骨腫瘤之治療 簡松雄

  1. 1. Block 7: Musculoskeletal System Limbsalvage of Bone and Soft-Tissue Tumors 骨科 簡松雄 Tel:07- 3208209 shchien@kmu.edu.tw1
  2. 2. Block 7: Musculoskeletal System Bone and Soft-Tissue Tumors 2
  3. 3. Block 7: Musculoskeletal System Bone and Soft-Tissue Tumors Enchondroma Chondroblastoma Chondrosarcoma Osteoblastoma Osteosarcoma Fibrosarcoma Myeloma Lymphoma Giant cell tumor Ewing’s sarcoma Osteochondroma Osteoid osteoma Maligant fibrous Histiocytoma Age(years) 0 10 20 30 40 50 60 70 FIGURE69-1. Age distribution of patients with bone tumor according to type. (Wilkins. R.M. and 3 Sim. F.H. Evaluation of Bone and Soft Tissue Tumors. In D Ambrosia R.D.(ed): Musculcskeletal Disorders Philadelphia J. B.Lippincou. 1986
  4. 4. Block 7: Musculoskeletal System Bone and Soft-Tissue Tumors 4
  5. 5. Block 7: Musculoskeletal System Clinical Approach to Musculoskeletal Tumors KMU PRACTICE GUIDELINES PATIENT COMPLAINT HISTORY AND PHYSICAL EXAMINATION SOFT TISSUE CLINICAL INFORMATION BONEIMAGE STUDY INTERPRETATION IMAGE STUDYLAB TEST TUMOR TUMOR LAB TEST SOFT TISSUE TUMOR BONE TUMOR DIFFFERENTIAL DIAGNOSIS PROBABLE PROBABLE BENIGN MALIGNANT BENIGN MALIGNANT METASTASES BIOPSY CLINICAL, RADIOGRAPHIC, AND PATHOLOGIC CORRELATION DIAGNOSIS SURGICAL STAGING 5 TREATMENT DESIGN Bone and Soft-Tissue Tumors
  6. 6. Block 7: Musculoskeletal System Bone and Soft-Tissue Tumors Surgical Margin of Musculoskeletal Tumors Musculoskeletal Cancer Surgery 6 M.M.Malawer 2001
  7. 7. Block 7: Musculoskeletal System Material and Method-1 Time: 1989---2005 Case: 33 patients, 38 prosthesis ( 5 revision) Sex: 15 male, 18 female Age: 15---63 y/o, average: 28 y/o primary malignant: 22 y/o metastases: 45 y/o Tumor: osteosarcoma– 19, malignant lymphoma– 2 malignant GCT-- 3, admantinoma– 1 chondrosarcoma—1, MFH—1 7 soft part sarcoma—1, metastases--5
  8. 8. Block 7: Musculoskeletal System Material and Method-2 Anatomic location: distal femur– 14, proximal femur– 5 total femur– 1 proximal tibia – 6 proximal humerus– 3 pelvic– 2 diaphysis-- 2 (humerus-1, tibia-1) Tumor prosthesis: knee joint– 21 (femur-15, tibia-6) hip joint—8 (saddle-2, THR-3, bipolar-3) shoulder joint– 3 8 intercalate diaphysis—2(humerus-1, tibia-1)
  9. 9. Block 7: Musculoskeletal System Results-1 9
  10. 10. Block 7: Musculoskeletal System Results-21. Functional scores of M-S Tumor Society: (motion , pain , stability/deformity , strength , functional activities , emotional acceptance ) - Excellent=5 , Good=3 , fair=1 , Poor=0 average 24 (13---28) , 80% normal function (30)2. Complication : aseptic loosen 2 ( revision) stem broken 1 (revision) stem migration 1 (observation) hinge broken 2 (revision) 10 infection 3 ( 1 A-K amputation)
  11. 11. Block 7: Musculoskeletal System Discussion 1. Satisfied functional result 2. Normal soft tissue envelope 3. Longevity of prosthesis 4. Infection rate 11
  12. 12. Block 7: Musculoskeletal System Malignant Tumor Non-Resection Resection IORT Re-Implantation Bone-Transplantation Prosthesis Only (60Gray) 1.Autoclave 1.Autograft Replacement (121-135 oC, a. free 1.Custom 5-15 min) b.vascular 2.Growing Rotation 2.Pasteurization c.lengthen Plasty (62 o C, 71 oC, 2.Allograft 3.Spacer 30min) 3.Xenograft 4. lengthen 3.after IORT Segment (extracorporeal) Amputation 4.alcoholization (95% A/C, 30 min) 5.Liquid N2, 30 min Utilization Bone of tumor Discarding Limb salvage Amputation 12 Bone and Soft-Tissue Tumors
  13. 13. Block 7: Musculoskeletal System Bone and Soft-Tissue TumorsBone Cancers KMU PRACTICE GUIDELINES EVALUATION TREATMENT FOLLOW-UP RECURRENCE P’t complain S/S Diagnosis(special fig.) Follow-up Local H&P •Osteosarcoma •Chondrosarcoma -every 3 mo for yr1+2 •Repeat •Ewing’s Sarcoma primary Bone lesion -every 4 mo for yr 3 Chest x-ray •Other primary malignant treatment Lab studies •Carcinoma Metastases -every 6 mo for yr 4+5 MRI + CT -every 1 yr for yr 6-10 Surgery Biopsy •En block resection •Physical examination Systemic • needle •Reconstruction •X-ray of lesion metastases (CT,Echo) •Wide margins •open •Limbsalvage if possible •Chest x-ray •Lung only: •frozen •Amputation •Bone scan resection+C/T Chemotherapy C/T •Lab test •Other sites: •Preoperation •Chest CT if abnormal Best Bone scan •Single •Postoperation supportive •Multiple x-ray finding Radiotherapy R/T Treatment 13Staging •Preoperation •Postoperation
  14. 14. Block 7: Musculoskeletal SystemSoft-tissue Sarcomas KMU PRACTICE GUIDELINES EVALUATION TREATMENT MODALITY FOLLOW-UP RECURRENCE P’t complain Surgery Low grade, Local: S/S •En block resection Effective wide H&P •Wide margins Repeat Resectable margin Soft tissue •Limbsalvage if possible treatment mass •Amputation Follow-up: -every 3 mo for yr1+2 Echo -every 4 mo for yr 3 Chest x-ray -every 6 mo for yr 4+5 •High grade -every 1 yr for yr 6-10 Lab studies •Physical examination •No effective MRI + CT Resectable •X-ray of lesion wide margin •Chest x-ray •Galium scan Biopsy •Lab test •Chest CT if abnormal • Needle x-ray finding (CT,Echo) Unresectable •Open Radiotherapy •Frozen •Galium scan Chemotherapy Metastases: •Doxorubicin •Single organ—debulking tumor,or •Single •Ifosfamide metastasectomy ,+R/T ,+C/T •Multiple •Disseminated---- palliative surgery, Metastases •TPOG-RMS-95 best supportive treatment 14Staging Bone and Soft-Tissue Tumors
  15. 15. Block 7: Musculoskeletal System Bone and Soft-Tissue Tumors Summary / take home message  Oncologic team work for treatment of cancer patients  The current trend of surgical method for malignant tumors is limbsalvage more than amputation 15
  16. 16. Block 7: Musculoskeletal System Bone and Soft-Tissue Tumors THANKS FOR YOUR ATTENTION 16

×